Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shima

Showing results (251-260 of 262) with videos related to

Pageof 27
Sort By:
Journal of Thrombosis and Haemostasis : JTH|May 20, 2008
Establishment of embryonic stem cells secreting human factor VIII for cell-based treatment of hemophilia AS Kasuda, A Kubo, Y Sakurai, et al.
British Journal of Haematology|November 5, 1997
Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphismS Morichika, M Shima, S Kamisue, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 15, 2018
Principles of haemophilia care: The asia pacific perspective. ResponseS Dunkley, J C M Lam, M J John, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2018
Principles of haemophilia care: The Asia-Pacific perspectiveS Dunkley, J C M Lam, M J John, et al.
Thrombosis and Haemostasis|May 1, 1997
Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopesH Suzuki, M Shima, M Arai, et al.
Thrombosis and Haemostasis|October 6, 2000
An alloantibody recognizing the FVIII A1 domain in a patient with CRM reduced haemophilia A due to deletion of a large portion of the A1 domain DNA sequenceM Shibata, M Shima, S Morichika, et al.
Clinical Genetics|April 26, 2008
Severe mandibuloacral dysplasia caused by novel compound heterozygous ZMPSTE24 mutations in two Japanese siblingsY Miyoshi, M Akagi, A K Agarwal, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 20, 2012
Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd reportA Shirahata, K Fukutake, J Mimaya, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 4, 2011
Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trialA Shirahata, K Fukutake, J Mimaya, et al.
International Journal of Hematology|August 16, 2001
Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitorsA Shirahata, T Kamiya, J Takamatsu, et al.
Pageof 27

Showing results (251-260 of 262) with videos related to

Sort By:
Pageof 27
Journal of Thrombosis and Haemostasis : JTH|May 20, 2008
Establishment of embryonic stem cells secreting human factor VIII for cell-based treatment of hemophilia AS Kasuda, A Kubo, Y Sakurai, et al.
British Journal of Haematology|November 5, 1997
Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphismS Morichika, M Shima, S Kamisue, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 15, 2018
Principles of haemophilia care: The asia pacific perspective. ResponseS Dunkley, J C M Lam, M J John, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2018
Principles of haemophilia care: The Asia-Pacific perspectiveS Dunkley, J C M Lam, M J John, et al.
Thrombosis and Haemostasis|May 1, 1997
Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopesH Suzuki, M Shima, M Arai, et al.
Thrombosis and Haemostasis|October 6, 2000
An alloantibody recognizing the FVIII A1 domain in a patient with CRM reduced haemophilia A due to deletion of a large portion of the A1 domain DNA sequenceM Shibata, M Shima, S Morichika, et al.
Clinical Genetics|April 26, 2008
Severe mandibuloacral dysplasia caused by novel compound heterozygous ZMPSTE24 mutations in two Japanese siblingsY Miyoshi, M Akagi, A K Agarwal, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 20, 2012
Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd reportA Shirahata, K Fukutake, J Mimaya, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 4, 2011
Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trialA Shirahata, K Fukutake, J Mimaya, et al.
International Journal of Hematology|August 16, 2001
Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitorsA Shirahata, T Kamiya, J Takamatsu, et al.
Pageof 27